Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure CC transcript Appointed director Inv. presentation Appointed CFO
|
PDL BIOPHARMA, INC. (PDLI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/10/2023 |
SC 13G/A
| DIMENSIONAL FUND ADVISORS LP reports a 6.5% stake in PDL BioPharma Inc |
02/08/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/11/2021 |
SC 13G/A
| Park West Asset Management LLC reports a 12.6% stake in PDL Biopharma, inc. |
08/28/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 9.4% stake in PDL BIOPHARMA INC |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/08/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/06/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2018 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.4% stake in PDL BioPharma Inc |
01/23/2018 |
SC 13G/A
| BlackRock Inc. reports a 9.5% stake in PDL BIOPHARMA INC |
02/14/2017 |
SC 13G/A
| RENAISSANCE TECHNOLOGIES LLC reports a 7.8% stake in PDL BIOPHARMA, INC. |
02/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/31/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
01/25/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/11/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/12/2013 |
SC 13G/A
| RENAISSANCE TECHNOLOGIES LLC reports a 8% stake in PDL BIOPHARMA, INC. |
09/10/2012 |
SC 13G/A
| PDL BIOPHARMA, INC. reports a 4.3% stake in PDL BIOPHARMA INC |
02/14/2012 |
SC 13G/A
| PDL BIOPHARMA, INC. reports a 9.9% stake in PDL BIOPHARMA INC |
02/13/2012 |
SC 13G/A
| PDL BIOPHARMA, INC. reports a 5.7% stake in PDL BIOPHARMA INC |
02/13/2012 |
SC 13G/A
| PDL BIOPHARMA, INC. reports a 2% stake in PDL Biopharma, Inc. |
02/13/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/13/2012 |
SC 13G/A
| PDL BIOPHARMA, INC. reports a 7.9% stake in PDL BIOPHARMA, INC. |
02/09/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/06/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/11/2011 |
SC 13G/A
| WHITEBOX ADVISORS LLC reports a 1.1% stake in PDL Biopharma Incorporated |
|
|
|